August 20th 2025
Nine months after initiation of androgen deprivation therapy (ADT), prostate cancer patients with higher myocardial extracellular volume (ECV) — derived from chest contrast-enhanced CT — had over a fourfold higher risk for major adverse cardiovascular events (MACEs), according to new research.
CMS Declines to Expand Coverage of Computed Tomography Colonography (CTC) for Medicare Beneficiaries
July 7th 2022Citing “insufficient” evidence, the Centers for Medicare and Medicaid Services (CMS) has declined a formal request by the American College of Radiology and multiple patient advocacy groups to reevaluate the lack of Medicare and Medicaid coverage of computed tomography colonography (CTC) for colorectal cancer screening.
Philips Adds Proteomic Nodule Risk Assessment to Lung Cancer Orchestrator System
June 30th 2022The addition of Biodesix’s Nodify Lung nodule risk assessment tool to Philips’ lung cancer patient management system may enhance diagnostic efficiency and facilitate improved management of high-risk patients.
Colorectal Cancer Screening: Could a Lower Age Threshold Reveal Greater Screening Disparities?
June 30th 2022In a large study looking at the use of colorectal cancer screening techniques (including computed tomography (CT) colonography) between 2000 and 2018, researchers found that the 50 to 54 age group had the lowest increases in screening and a significantly higher chasm of racial and socioeconomic disparities in comparison to other age groups.
AI Software Facilitates 22.1 Percent Reduction in Chest CT Review Time
June 17th 2022Noting that an AI software platform could save radiologists up to an hour a day in interpreting chest computed tomography (CT) scans, the authors of a prospective study found shorter mean interpretation times with non-contrast and contrast-enhanced CT as well as positive CT scans with and without significant new findings.
Siemens Healthineers Get FDA Nod for New SPECT/CT Scanner
June 12th 2022The newly FDA-cleared Symbia Pro.specta SPECT/CT Scanner, which reportedly offers a variety of enhanced capabilities including low-dose CT up to 64 slices and intuitive workflow guides, was launched at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting.
Study Suggests the COVID-19 Pandemic Led to Millions of Decreased Cancer Screenings
June 6th 2022A new survey study from the American Cancer Society shows a 4.47 million decrease in cervical cancer screenings and a 2.13 million decrease in breast cancer screenings in the United States between 2018 and 2020.
Can Diffusion-Weighted MRI Have an Impact in Detecting Recurrent Pancreatic Cancer?
May 29th 2022For post-op monitoring of patients who had pancreatic ductal adenocarcinoma (PDAC) resection, a new study showed that diffusion-weighted magnetic resonance imaging (MRI) had enhanced sensitivity for detecting recurrent tumors in comparison to conventional MRI.
AI May Bolster Assessment of Pulmonary Nodules on Chest CT
May 24th 2022A new study revealed that an emerging artificial intelligence (AI)-enabled software tool led to improved sensitivity, specificity and inter-observer agreement for the diagnosis of indeterminate pulmonary nodules on chest computed tomography (CT) scans.
Iodinated Contrast Media: 15 Recommendations for Addressing the Shortage
May 12th 2022Given the challenges with the shortage of the iodinated contrast agent Omnipaque, national and state organizations have issued suggested risk mitigation and conservation strategies to reprioritize imaging needs during this temporary shortage.
New Study Shows Impact of COVID-19 and Comorbidities in Inner-City Lung Screening Cohort
May 1st 2022In a lung screening cohort of over 2,500 people, researchers found that significantly higher rates of chronic kidney disease and chronic heart failure were associated with increased hospitalization and mortality rates in patients with COVID-19.